Simultaneously, through synergy with TRP receptors, SOCE machinery and mitochondrial membranes, these compounds bolster insulin sensitivity, ramp up energy expenditure and fine-tune lipid metabolism—underscoring their compelling therapeutic promise for obesity and metabolic syndrome [52]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.